Nancy Lapid

(Reuters) – The following summarizes recent research on COVID-19. There is some research that needs to be further investigated to verify the results and has not been peer reviewed.

Omicron multiplies faster in airways, slower in lungs

Researchers believe that Omicron may have an effect on how well other coronavirus variants multiply, as evidenced by major differences.

Omicron is 70x faster than the Delta version. These tissues line airway passageways, and Omicron may be able to spread from person to person, researchers said. Omicron replication in lung tissues is 10 times slower that the original coronavirus. That could lead to less serious illnesses.

While a peer-reviewed report has been published, the formal findings have not yet been made public by the research group. Hong Kong University released a press release stating that Dr. Michael Chan Chiwai, the study leader, said “It’s important to understand that disease severity is not solely determined by virus replication”. He added, however, that it is also affected by the immune system of each patient, which can lead to severe inflammation.

Chan stated, “By infecting more people, an extremely infectious virus could cause more severe diseases and deaths, even though the virus itself might be less dangerous.” This, combined with recent findings that Omicron can partially escape vaccine immunity and previous infection suggests Omicron variant’s overall threat to human health is very real.

Omicron holds cells tighter and withstands certain antibodies.

According to scientists, a structural model showing how Omicron variant attaches cells to antibodies will shed light on this behavior. It can also be used to help design neutralizing antibody designs.

They used computer models to analyze molecular interactions that occur when Omicron spikes onto ACE2, a protein found on the surface of Omicron cells, and they also analyzed the viral gateway.

Joseph Lubin, Rutgers University of New Jersey stated that Omicron’s grasp “looks more as a couple holding hands with their fingertips entwined.” Metaphorically the virus used ACE2 to infect its original host. Lubin said that Omicron’s mutations may cooperate with the grip to infect cells.

A variety of antigens were also used to model the spike. Lubin explained that different antibodies strike from different directions, much like how a team of football players might attack a ball carrier. One antibody grabs from the back, while another takes aim from the front. While some antibodies may be “shaken off,” others will likely remain active. Lubin explained that booster vaccines can increase antibody levels. They might also make it more difficult for some antibodies to hold on, which could compensate in part for a weaker grip.

Lubin stated that the findings were posted Monday to bioRxiv before peer review. However, they need to be confirmed “especially with real-world samples taken from individuals.” While our predictions of molecular structures are not final on Omicron (we hope), they allow for a quicker and more efficient response by the global community.

Unknowingly spreading virus to 4 out of 10 infected persons

People infected with SARS-CoV-2 may not show symptoms, which could be contributing to the transmission of the virus. This is because they are responsible for 40% of confirmed COVID-19 infections, as per a JAMA Network Open study.

Researchers gathered data from 77 previous studies that included 19,884 people with confirmed SARS/CoV-2 infection. Researchers found that about 40% of people with confirmed SARS-CoV-2 infections were infected in the general population.

Asymptomatic infections were approximately 46% in North America and 44% in Europe, respectively. In Asia, it was 28%.

Min Liu, a Peking University colleague in China wrote that “the high number of asymptomatic infection highlights the potential transmission risk for asymptomatic infectious diseases in communities.” Asymptomatic infections should be identified by officials. Those who have been diagnosed “should receive treatment similar to those for confirmed infections.”

Click for a Reuters graphic https://tmsnrt.rs/3c7R3Bl on vaccines in development.